INVUITY, INC.
SAN FRANCISCO, CA

Invuity, Inc., established in early 2018 and based out of Florida but headquartered in San Francisco, specializes in enhancing surgical procedures through intelligent photonics technology. Their aim is to improve direct visualization during minimally invasive surgeries by providing advanced illumination beyond what traditional operating room lights can offer. The focus is on making surgical operations more efficient and safer. The company’s Intelligent Photonics technology is at the forefront of their offerings, integrating modified optical waveguides with standard surgical equipment like xenon and LED light sources. This ensures that surgeons have a well-lit view during procedures, no matter how complex they are. Invuity's commitment to innovation extends across a wide range of minimally invasive operations, seeking both clinical excellence and economic efficiency. Leadership within the company includes Joe Guido, Vice President of Commercial Marketing & Business Development since April 2016, who brings strategic insight into commercial growth and product development. Steve Annen holds dual responsibilities as VP of Product Management and Strategy, while board member Gregory T. Lucier from NuVasive contributes significant industry expertise. A pivotal moment in the company’s journey was its public offering in March 2018 when Invuity offered six million two hundred thousand shares at $3.50 each. Additionally, its ongoing efforts to innovate are evident in its publicly traded status under NASDAQ: IVTY, with a recent annual report submitted on March 20, 2024. Overall, Invuity remains dedicated to advancing and refining medical technologies, particularly within minimally invasive surgery, ensuring that it stays at the forefront of this critical field.